dehydroepiandrosterone has been researched along with cyclic gmp in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higuchi, K; Ibayashi, H; Kato, K; Matsuo, H; Nawata, H | 1 |
| Beer, N; Jakubowicz, D; Rengifo, R | 1 |
| Farrukh, IS; Hoidal, JR; Orlinska, U; Peng, W | 1 |
| Farrukh, IS; Hoidal, JR; Peng, W | 1 |
| Asai, Y; Esaki, T; Hayashi, T; Iguchi, A; Jayachandran, M; Kano, H; Muto, E; Sumi, D; Thakur, NK | 1 |
| Cap, A; Leopold, JA; Loscalzo, J; Scribner, AW; Stanton, RC | 1 |
| Dillon, JS; Liu, D | 1 |
| Benso, A; Ghigo, E; Gigliardi, VR; Granata, R; Martina, V; Masha, A; Origlia, C | 1 |
| Fagan, KA; Gebb, SA; Golembeski, SM; Homma, N; Imamura, M; Karoor, V; Limbird, J; McMurtry, IF; Nagaoka, T; Oka, M; Sakao, E | 1 |
| Agustí, A; Cauli, O; Felipo, V; González-Usano, A | 1 |
| Gomez, GI; Moreno, M; Muñoz, YC; Solis, CL; Valladares, LE; Velarde, V | 1 |
1 trial(s) available for dehydroepiandrosterone and cyclic gmp
| Article | Year |
|---|---|
Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects.
Topics: Aged; Atherosclerosis; Biomarkers; Blood Chemical Analysis; Blood Platelets; Cyclic GMP; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; Humans; Male; Middle Aged; Nitric Oxide; Vasodilator Agents | 2006 |
10 other study(ies) available for dehydroepiandrosterone and cyclic gmp
| Article | Year |
|---|---|
Alpha-human atrial natriuretic polypeptide inhibits steroidogenesis in cultured human adrenal cells.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aldosterone; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Dehydroepiandrosterone; Humans; Hydrocortisone | 1986 |
Effect of dehydroepiandrosterone on cyclic-guanosine monophosphate in men of advancing age.
Topics: Cyclic GMP; Dehydroepiandrosterone; Double-Blind Method; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Nitric Oxide | 1995 |
Effect of dehydroepiandrosterone on hypoxic pulmonary vasoconstriction: a Ca(2+)-activated K(+)-channel opener.
Topics: Animals; Cell Hypoxia; Cells, Cultured; Cyclic AMP; Cyclic GMP; Dehydroepiandrosterone; Ferrets; Ion Channel Gating; Large-Conductance Calcium-Activated Potassium Channels; Muscle, Smooth, Vascular; Potassium Channels; Potassium Channels, Calcium-Activated; Pulmonary Alveoli; Pulmonary Circulation; Pulmonary Wedge Pressure; Tetraethylammonium; Vasoconstriction | 1998 |
Role of a novel KCa opener in regulating K+ channels of hypoxic human pulmonary vascular cells.
Topics: 4-Aminopyridine; Cell Hypoxia; Cells, Cultured; Charybdotoxin; Cyclic AMP; Cyclic GMP; Dehydroepiandrosterone; Egtazic Acid; Enzyme Inhibitors; Humans; Membrane Potentials; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Inwardly Rectifying; Potassium Channels, Voltage-Gated; Protein Kinase Inhibitors; Pulmonary Circulation; Thionucleotides | 1999 |
Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide.
Topics: Acetylcholine; Adjuvants, Immunologic; Animals; Aorta, Thoracic; Aromatase; Arteriosclerosis; Calcimycin; Cholesterol, Dietary; Cyclic GMP; Dehydroepiandrosterone; Diet, Atherogenic; Electrodes; Endothelium, Vascular; Estrogens; Female; Ionophores; Nitrates; Nitric Oxide; Nitrites; Rabbits; Triglycerides; Vasodilation; Vasodilator Agents | 2000 |
Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability.
Topics: Animals; Aorta; Cattle; Cyclic GMP; Dehydroepiandrosterone; Endothelium, Vascular; Enzyme Inhibitors; Glucosephosphate Dehydrogenase; Hydrogen Peroxide; NADP; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oligonucleotides, Antisense; Oxidative Stress; Pteridines; Pterins; Reactive Oxygen Species; Transfection | 2001 |
Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor.
Topics: Adjuvants, Immunologic; Animals; Aorta; Cattle; Cells, Cultured; Cyclic GMP; Dehydroepiandrosterone; Endothelium, Vascular; Enzyme Activation; Estrogen Antagonists; Estrogens; Humans; Mitogen-Activated Protein Kinase Kinases; Nitric Oxide; Nitric Oxide Synthase; Pertussis Toxin; Protein-Tyrosine Kinases; Receptors, Cell Surface; Tamoxifen; Time Factors; Umbilical Veins | 2004 |
Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.
Topics: Acetylcholine; Animals; Blotting, Western; Cyclic GMP; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Guanylate Cyclase; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Lung; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroprusside; Pulmonary Artery; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Testosterone; Up-Regulation; Vasodilator Agents | 2007 |
Differential modulation of the glutamate-nitric oxide-cyclic GMP pathway by distinct neurosteroids in cerebellum in vivo.
Topics: Animals; Cerebellum; Cyclic GMP; Dehydroepiandrosterone; gamma-Aminobutyric Acid; Glutamic Acid; Male; N-Methylaspartate; Neurotransmitter Agents; Nitric Oxide; Pregnanolone; Pregnenolone; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2011 |
Dehydroepiandrosterone prevents the aggregation of platelets obtained from postmenopausal women with type 2 diabetes mellitus through the activation of the PKC/eNOS/NO pathway.
Topics: Blood Platelets; Cyclic GMP; Dehydroepiandrosterone; Diabetes Mellitus, Type 2; Enzyme Activation; Enzyme Inhibitors; Female; Humans; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Phosphoserine; Platelet Aggregation; Postmenopause; Protein Kinase C-delta; Signal Transduction | 2012 |